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ABSTRACT
We report on a 27-year-old patient presenting with chronic
hypokalaemia, inappropriate kaliuresis, hypomagnesaemia
and alkalosis, associated with moderate proteinuria. Genetic
analysis evidenced a homozygous mutation (p.Arg399Cys) in
the SLC12A3 gene coding for the sodium-chloride cotranspor-
ter (NCC), conﬁrming the diagnosis of Gitelman syndrome.
Further genetic testing did not show any mutation in NPHS2.
A renal biopsy was performed in view of the unusual associ-
ation with proteinuria. Light microscopy showed hypertrophy
of the juxtaglomerular apparatus and discrete mesangial
thickening. In addition to possible focal segmental glomerular
sclerosis lesions, electron microscopy showed extensive seg-
ments of variably thickened glomerular basement membrane
(GBM), contrasting with segments of regular GBM of low
range thickness, and effacement of podocyte foot processes.
Of interest, alterations of the GBM were also observed in a
Slc12a3 knock-out mouse model for Gitelman syndrome.
These data suggest that the association between Gitelman
syndrome and secondary changes of the GBM is probably
not coincidental. Possible mechanisms include angiotensin
II- or renin-induced podocyte lesions, as well as chronic
hypokalaemia.
Keywords: glomerular basement membrane, hypokalaemia,
secondary aldosteronism, tubulopathy
INTRODUCTION
Gitelman syndrome is a recessively inherited salt-losing tubu-
lopathy characterized by hypokalaemia, hypomagnesaemia,
inappropriate kaliuresis and hypocalciuria. The majority of
cases are caused by loss of function mutations in the SLC12A3
gene coding for the thiazide-sensitive sodium-chloride cotran-
sporter (NCC), normally expressed in the apical membrane of
the renal distal convoluted tubule [1]. Gitelman syndrome is
considered as the most frequent inherited tubulopathy, with a
prevalence of heterozygotes at ∼1% in European populations
[2]. Although Gitelman syndrome is a disease of the distal
tubule, there have been few reported cases associated with glo-
merular lesions including focal segmental glomerulosclerosis
(FSGS) [3] and C1q nephropathy [4]. To date, no association
of Gitelman syndrome with abnormal ﬁndings of the glomeru-
lar basement membrane (GBM) has been reported.
CASE REPORT
A 27-year-old Caucasian man was referred for evaluation of
hypokalaemia, hypomagnesaemia and moderate proteinuria.
His past medical history included tetany at the age of 16 years,
which led to the discovery of hypokalaemia and hypomagne-
saemia. The patient complained of salt craving, polydypsia
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and occasional nocturia. He had frequent cramps in the calves
and paresthesias of the face and hands. Physical examination
revealed a sitting blood pressure of 100/75 mmHg. Laboratory
tests conﬁrmed hypokalaemia (2.5 mmol/L), hypomagnesaemia
(1.17 mmol/L) and alkalosis (plasma bicarbonate 33 mmol/L).
Kidney function was normal (plasma creatinine 0.95 mg/dL,
eGFR 95 mL/min/1.73 m2). Urinalysis revealed inappro-
priate kaliuresis (104 mmol/24 h), abundant natriuresis (266
mmol/24 h), hypocalciuria (<20 mg/24 h) and proteinuria
of 770 mg/24 h. Proteinuria, mostly albuminuria, was con-
ﬁrmed at 1200 mg/24 h in a second sample. Beta-2 microglo-
bulinuria was normal (<0.2 mg/L) and the urinary sediment
was bland.
Sequence analysis of the SLC12A3 gene revealed a homozy-
gous mutation in exon 10 (c.1195C>T). This change, which is
predicted to substitute the arginine at codon 399 by a cysteine
residue (p.Arg399Cys, R399C), is considered to be a recur-
rent-disease causing mutation (variation: CM014400) [5]. The
mutation was found at the heterozygous state in the father and
at the homozygous state in the sister of the patient. None of
them had proteinuria. There was no mention of consanguinity
in this family. Of note, the parents of the proband originate
from two villages located in the eastern part of Belgium where
the R399C variant has been detected previously in unrelated
cases.
The unusual association of Gitelman syndrome and protei-
nuria in the proband prompted us to perform a renal biopsy
(Figure 1). Light microscopy showed hypertrophy of the juxta-
glomerular apparatus and discrete mesangial thickening
without hypercellularity. There was no interstitial ﬁbrosis or
tubular atrophy. No immune deposits were detected by immu-
noﬂuorescence. Two small glomerular tufts limited by a
thickened Bowman’s capsule containing patent capillary loops
with a slightly increased thickness of their wall were available
in the sample for electron microscopic examination. In some
areas, the observation of lipoprotein droplets in the cytoplasm
of podocytes occasionally detached from smooth regular but
collapsed glomerular basement membranes is consistent with
the development of FSGS lesions. In addition, there were
extensive segments of variably thickened GBM with clariﬁca-
tions and densities, contrasting with segments of smooth
regular GBM. All these altered GBMs displayed quite extensive
effacement of foot processes but preservation of the slit dia-
phragms (Figure 1). The glomerular lesions motivated a
further sequence analysis of the exons and ﬂanking intronic
regions of the NPHS2 gene to exclude the presence of the
R229Q variant, which is present in 3.6% of controls and con-
sidered as a susceptibility factor for late-onset FSGS [6]. This
analysis did not show any aberration in the NPHS2 sequence
of the proband.
F IGURE 1 : Renal biopsy of the index case presenting with Gitelman syndrome and glomerular proteinuria. Upper panel: (Masson’s trichrome
green, obj. ×4, and blue (insert), obj. ×20). Light microscopic examination showed hypertrophy of the juxtaglomerular apparatus (arrows) and
discrete mesangial thickening without hypercellularity. There were no interstitial ﬁbrosis and no tubular atrophy or additional parenchymal
alterations. No immune deposits were detected by immunoﬂuorescence. Lower panels: (Epon, lead stain) Electron microscopy revealed signiﬁ-
cant alterations of the glomerular basement membrane (GBM), with extensive segments presenting severe irregular contours varying in thick-
ness containing clariﬁcations and densities (asterisk) or with smooth regular contours of GBM at the lower range of thickness (mean: 306 nm)
(arrow). All altered GBMs display quite extensive effacement of foot processes (arrowhead). C, glomerular capillary lumen; US, urinary space.
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In order to substantiate the potential association of glomer-
ular defects with Gitelman syndrome, we analysed kidneys
from Slc12a3 knock-out mice and their littermate controls [7].
Although the glomeruli of NCC-deﬁcient mice appeared
normal at the light microscopy level, electron microscopy
showed several circumscribed GBM protrusion. These irregular
GBM thicknesses were accompanied by focal foot process efface-
ments and the occasional formation of pseudocysts in podocytes
(Figure 2). These changes, not observed in the kidneys of control
mice, were similar to those seen in the proband.
DISCUSSION
To our knowledge, we report here the ﬁrst case of genetically
proven Gitelman syndrome associated with glomerular protei-
nuria and signiﬁcant abnormalities of the GBM. Defects of the
GBM and podocytes were also detected in the Slc12a3 knock-
out mouse model. The lesions observed in the index case and
the mouse model points to a possible link between the func-
tional loss of NCC and podocyte dysfunction. The R399C
mutation detected in the homozygous state in the proband is
known to be particularly severe. Functional studies in Xenopus
oocytes showed that R399C mutants are not complex glycosy-
lated, absent from the plasma membrane, and non-functional,
and they have been identiﬁed in a subset of severely affected
males [5].
Salt-losing tubulopathies are not classically associated with
proteinuria, and the few renal biopsies available most often
show hyperplasia of the juxtaglomerular apparatus, with no
glomerular and no tubular abnormalities [8]. However, a ret-
rospective analysis of patients with genetically proven Gitel-
man syndrome revealed proteinuria with preserved renal
function in 6/36 patients. Three of these six patients were hy-
pertensive; no renal biopsy was performed [9]. Isolated cases
of FSGS [3] and C1q nephropathy [4] have also been reported
in association with Gitelman syndrome. Long-term follow-up
of patients with classic Bartter syndrome secondary to biallelic
mutations in CLCNKB showed mild to moderate glomerular
proteinuria in 6/13 patients, with associated microhaematuria
in two of the six patients. Renal biopsy performed in two
patients revealed mesangial expansion/hypertrophy without
juxtaglomerular apparatus hypertrophy [10]. No ultrastructur-
al examination of the glomeruli was reported.
What could account for the association of Gitelman syn-
drome with podocyte defects and subsequent alteration of the
GBM and proteinuria?
One hypothesis is that the chronic activation of the renin-
angiotensin-aldosterone pathway, leading to increased sys-
temic and local levels of angiotensin-II and renin, may in turn
cause podocyte lesions. Angiotensin-II can induce proteinuria
through haemodynamic and non-haemodynamic mechanisms
involving the vascular endothelial growth factor (VEGF) and
transforming growth factor (TGF)-β1 [11]. Of note, GBM
F IGURE 2 : Histological analysis of glomeruli from Slc12a3 knock-out mice. Glomeruli were normal by light microscopy (A, Epon semi-thin
section stained with methylene blue and azure II). Electron microscopy of glomeruli of NCC-deﬁcient mice (B–D, Epon ultra-thin section lead
citrate and uranyl acetate). Aside regions with normal appearing GBM (arrows), the GBM shows occasionally prominent protrusions (asterisks)
that extend towards the attached podocyte (P). The GBM remains completely covered by the foot processes of the podocytes, but in areas with
GBM thickenings foot process effacement (arrowheads) is observed. Occasionally, podocytes show the formation of pseudocysts (hatch) where
the foot processes appear to pulled out to thin cell projections. Cap, capillary loop; PEC, parietal epithelial cell. Kidneys of four adult wild-type
and four NCC-deﬁcient male mice were analysed.
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alterations including heterogeneity and disappearance of the
foot processes, with decreased expression of nephrin and
podocin, have been described in transgenic mice overexpres-
sing renin [12]. Nephrotic proteinuria was also reported in
patients with Addison’s disease, another condition associated
with hyperreninaemia. Renal biopsy revealed focal segmental
glomerular sclerosis and nodular deposits of IgM and C3 [13].
Furthermore, a severe, non-apoptotic detachment of podo-
cytes has been described in one case of Gitelman syndrome,
also associated with reduced nephrin expression in the kidney
[14]. Chronic hypokalaemia may also play a role. Reungjui
et al. detected mild proteinuria in hypokalaemic rats given a
normal or moderately low potassium diet, with or without
hydrochlorothiazide. For the same degree of hypokalaemia,
focal glomerular injury was more evident in rats treated with
hydrochlorothiazide than in those under low potassium diet,
which was attributed to secondary aldosteronism resulting
from volume depletion [15].
Altogether, these data suggest that the association of Gitel-
man syndrome and glomerular proteinuria with abnormal
ﬁndings of the glomerular basal membrane is probably not
coincidental. With increasing awareness for rare inherited
kidney disorders and increased number of patients, one can
predict that rare complications will emerge. Recently, impaired
renal phosphate handling [16], secondary hypertension [9, 17]
and CKD [17, 18] have been associated with Gitelman syn-
drome. Patients with Gitelman syndrome should be evaluated
for the presence of proteinuria and biopsied in the presence of
glomerular proteinuria.
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